1.Radiofrequency catheter ablation of idiopathic ventricular tachycardia and symptomatic premature ventricular contraction originating from valve annulus.
Xiao-yu WU ; Zhao-guang LIANG ; Zhen TAN ; Hong-yue GU ; Shu ZHANG ; Wei-min LI
Chinese Medical Journal 2008;121(22):2241-2245
BACKGROUNDRadiofrequency catheter ablation (RFCA) has been established as an effective and curative therapy for ventricular tachycardia (VT) and severely symptomatic premature ventricular contraction (PVC) from the outflow tract in structurally normal hearts. This study aimed to investigate electrophysiologic characteristics and effects of RFCA for patients with idiopathic VT and symptomatic PVC originating from the valve annulus.
METHODSCharacteristics of body surface electrocardiogram (ECG) and endocardiogram in a successful RFCA target were analyzed in 16 patients with idiopathic VT and symptomatic PVC originating from the valve annulus. Additionally, the ECG characteristics of VT or PVC were compared with those of manifest Wolff-Parkinson-White (WPW) syndrome originating from the same site of origin in 15 patients.
RESULTSThirteen patients were successful, 2 recurrent and 1 failed. The recurrent cases underwent successful ablation the second time guided by the Ensite 3000 mapping system. In all patients with the WPW syndrome, the characteristics of QRS morphology were well matched with those of the VT and PVC that originated from corresponding sites of origin.
CONCLUSIONSRFCA is an effective curative therapy for VT and symptomatic PVC originating from the valve annulus. There are specific characteristics in ECG and the ablation site could be located by means of the WPW syndrome accessory pathway's algorithm.
Adult ; Aged ; Catheter Ablation ; methods ; Electrocardiography ; Female ; Humans ; Male ; Middle Aged ; Mitral Valve ; physiopathology ; surgery ; Tachycardia, Ventricular ; physiopathology ; surgery ; Ventricular Premature Complexes ; physiopathology ; surgery
2.Quantification of mitral regurgitation using proximal isovelocity surface area method in dogs.
Hojung CHOI ; Kichang LEE ; Heechun LEE ; Youngwon LEE ; Dongwoo CHANG ; Kidong EOM ; Hwayoung YOUN ; Mincheol CHOI ; Junghee YOON
Journal of Veterinary Science 2004;5(2):163-171
The present study was performed to determine the accuracy and reproducibility of calculating the mitral regurgitant orifice area with the proximal isovelocity surface area (PISA) method in dogs with experimental mitral regurgitation and in canine patients with chronic mitral insufficiency and to evaluate the effect of general anesthesia on mitral regurgitation. Eight adult, Beagle dogs for experimental mitral regurgitation and 11 small breed dogs with spontaneous mitral regurgitation were used. In 8 Beagle dogs, mild mitral regurgitation was created by disrupting mitral chordae or leaflets. Effective regurgitant orifice (ERO) area was measured by the PISA method and compared with the measurements simultaneously obtained by quantitative Doppler echocardiography 4 weeks after creation of mitral regurgitation. The same procedure was performed in 11 patients with isolated mitral regurgitation and in 8 Beagle dogs under two different protocols of general anesthesia. ERO and regurgitant stroke volume (RSV) by the PISA method correlated well with values by the quantitative Doppler technique with a small error in experimental dogs (r = 0.914 and r = 0.839) and 11 patients (r = 0.990 and r = 0.996). The isoflurane anesthetic echocardiography demonstrated a significant decrease of RSV, and there was no significant change in fractional shortening (FS), ERO area, LV end-diastolic and LV end-systolic volume. ERO area showed increasing tendency after ketamine-xylazine administration, but not statistically significant. RSV, LV end-systolic and LV end-diastolic volume increased significantly (p < 0.01), whereas FS significantly decreased (p < 0.01). The PISA method is accurate and reproducible in experimental mitral regurgitation model and in a clinical setting. ERO area is considered and preferred as a hemodynamic-nondependent factor than other traditional measurements.
Anesthesia, Rectal
;
Animals
;
Body Surface Potential Mapping/*veterinary
;
Chordae Tendineae/physiopathology/surgery
;
Dog Diseases/diagnosis/*physiopathology
;
Dogs
;
Echocardiography, Doppler/veterinary
;
Electrocardiography/veterinary
;
Mitral Valve/*physiopathology
;
Mitral Valve Insufficiency/diagnosis/physiopathology/*veterinary
4.Percutaneous mitral valve repair with MitraClip for severe functional mitral regurgitation.
Khung Keong YEO ; Zee Pin DING ; Yeow Leng CHUA ; Soo Teik LIM ; Kenny Yoong Kong SIN ; Jack Wei Chieh TAN ; Paul Toon Lim CHIAM ; Nian Chih HWANG ; Tian Hai KOH
Singapore medical journal 2013;54(1):e9-e12
A 67-year-old Chinese woman with comorbidities of chronic obstructive lung disease, hypertension and prior coronary artery bypass surgery presented with severe functional mitral regurgitation (MR) and severely depressed left ventricular function. She was in New York Heart Association (NYHA) Class II-III. Due to high surgical risk, she was referred for percutaneous treatment with the MitraClip valve repair system. This procedure is typically performed via the femoral venous system and involves a transseptal puncture. A clip is delivered to grasp the regurgitant mitral valve leaflets and reduce MR. This was performed uneventfully in our patient, with reduction of MR from 4+ to 1+. She was discharged on post-procedure Day 2 and her NYHA class improved to Class I. This was the first successful MitraClip procedure performed in Asia and represents a valuable treatment option in patients with severe MR, especially those with functional MR or those at high surgical risk.
Aged
;
Cardiac Surgical Procedures
;
methods
;
Cardiology
;
instrumentation
;
methods
;
Catheters
;
Echocardiography
;
methods
;
Equipment and Supplies
;
Female
;
Heart Ventricles
;
physiopathology
;
Humans
;
Mitral Valve
;
surgery
;
Mitral Valve Insufficiency
;
surgery
;
Pulmonary Disease, Chronic Obstructive
;
complications
;
Risk
;
Ultrasonography, Doppler
;
methods
;
Ventricular Dysfunction, Left
;
surgery
5.Long-Term Echocardiographic Follow-up after Posterior Mitral Annuloplasty Using a Vascular Strip for Ischemic Mitral Regurgitation: Ten-Years of Experience at a Single Center.
Dong Seop JEONG ; Hae Young LEE ; Wook Sung KIM ; Kiick SUNG ; Tae Gook JUN ; Ji Hyuk YANG ; Pyo Won PARK ; Young Tak LEE
Journal of Korean Medical Science 2011;26(12):1582-1590
Management of ischemic mitral regurgitation (MR) is challenging. The aim of this study was to investigate long-term clinical and echocardiographic results of restrictive mitral annuloplasty for ischemic MR. From 2001 through 2010, 96 patients who underwent myocardial revascularization with restrictive mitral annuloplasty using a vascular strip for ischemic MR were analyzed. Patients were stratified into two groups based on left ventricular ejection fraction (LVEF): group I, n = 50, with LVEF > 35% and group II, n = 46, with LVEF < or = 35%. The early mortality rate was 2.1% (2/96) and the late cardiac mortality rate was 11.5% (11/96). MR grade was reduced at discharge (0.8 +/- 0.7) but increased during follow-up (1.1 +/- 0.8, P = 0.001). There was no intergroup difference in terms of freedom from recurrent MR > or = moderate eight years after surgery (94.1% +/- 5.7%, group I vs 87.8% +/- 7.2%, group II; P = 0.575). NYHA functional class (odds ratio [OR], 2.2; P = 0.044) and early postoperative residual MR > or = mild (OR, 25.4; P < 0.001) were independent predictors of recurrent MR. Restrictive mitral annuloplasty using a vascular strip is effective in ischemic MR. It is important to avoid early postoperative residual MR.
Aged
;
Aged, 80 and over
;
Coronary Artery Disease/mortality/*surgery
;
Echocardiography
;
Female
;
Follow-Up Studies
;
Heart Valve Prosthesis Implantation
;
Humans
;
Male
;
Middle Aged
;
Mitral Valve/physiopathology/*surgery
;
Mitral Valve Annuloplasty/*methods
;
Mitral Valve Insufficiency/mortality/*surgery
;
Myocardial Ischemia/mortality/*surgery
;
Myocardial Revascularization
;
Stroke Volume
;
Treatment Outcome
;
Vascular Surgical Procedures
6.Prosthesis-Patient Mismatch after Mitral Valve Replacement: Comparison of Different Methods of Effective Orifice Area Calculation.
In Jeong CHO ; Geu Ru HONG ; Seung Hyun LEE ; Sak LEE ; Byung Chul CHANG ; Chi Young SHIM ; Hyuk Jae CHANG ; Jong Won HA ; Namsik CHUNG
Yonsei Medical Journal 2016;57(2):328-336
PURPOSE: The incidence of prosthesis-patient mismatch (PPM) after mitral valve replacement (MVR) has been reported to vary. The purpose of the current study was to investigate incidence of PPM according to the different methods of calculating effective orifice area (EOA), including the continuity equation (CE), pressure half time (PHT) method and use of reference EOA, and to compare these with various echocardiographic variables. MATERIALS AND METHODS: We retrospectively reviewed 166 individuals who received isolated MVR due to rheumatic mitral stenosis and had postoperative echocardiography performed between 12 and 60 months after MVR. EOA was determined by CE (EOA(CE)) and PHT using Doppler echocardiography. Reference EOA was determined from the literature or values offered by the manufacturer. Indexed EOA was used to define PPM as present if < or =1.2 cm2/m2. RESULTS: Prevalence of PPM was different depending on the methods used to calculate EOA, ranging from 7% in PHT method to 49% in referred EOA method to 62% in CE methods. The intraclass correlation coefficient was low between the methods. PPM was associated with raised trans-prosthetic pressure, only when calculated by CE (p=0.021). Indexed EOA(CE) was the only predictor of postoperative systolic pulmonary artery (PA) pressure, even after adjusting for age, preoperative systolic PA pressure and postoperative left atrial volume index (p<0.001). CONCLUSION: Prevalence of mitral PPM varied according to the methods used to calculate EOA in patients with mitral stenosis after MVR. Among the various methods used to define PPM, EOA(CE) was the only predictor of postoperative hemodynamic parameters.
Adult
;
Aged
;
Echocardiography
;
Echocardiography, Doppler
;
Female
;
Heart Valve Diseases/*surgery
;
*Heart Valve Prosthesis
;
Heart Valve Prosthesis Implantation/*adverse effects/methods
;
Hemodynamics
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Mitral Valve/physiopathology/*surgery
;
Prevalence
;
Retrospective Studies
;
Treatment Outcome
7.Morphological variations of papillary muscles in the mitral valve complex in human cadaveric hearts.
Sandhya Arvind GUNNAL ; Rajendra Namdeo WABALE ; Mujeebuddin Samsamuddin FAROOQUI
Singapore medical journal 2013;54(1):44-48
INTRODUCTIONPapillary muscle rupture and dysfunction can lead to complications of prolapsed mitral valve and mitral regurgitation. Multiple operative procedures of the papillary muscles, such as resection, repositioning and realignment, are carried out to restore normal physiological function. Therefore, it is important to know both the variations and the normal anatomy of papillary muscles.
METHODSThis study was carried out on 116 human cadaveric hearts. The left ventricles were opened along the left border in order to view the papillary muscles. The number, shape, position and pattern of the papillary muscles were observed.
RESULTSIn this series, the papillary muscles were mostly found in groups instead of in twos, as is described in standard textbooks. Four different shapes of papillary muscles were identified - conical, broad-apexed, pyramidal and fan-shaped. We also discovered various patterns of papillary muscles.
CONCLUSIONNo two mitral valve complexes have the same architectural arrangement. Each case seems to be unique. Therefore, it is important for scientists worldwide to study the variations in the mitral valve complex in order to ascertain the reason behind each specific architectural arrangement. This will enable cardiothoracic surgeons to tailor the surgical procedures according to the individual papillary muscle pattern.
Adult ; Anatomy ; methods ; Cadaver ; Chordae Tendineae ; anatomy & histology ; Heart ; anatomy & histology ; Humans ; Middle Aged ; Mitral Valve ; pathology ; Mitral Valve Insufficiency ; physiopathology ; Models, Anatomic ; Papillary Muscles ; pathology ; Thoracic Surgery ; methods
8.Relationship between early spontaneous cardioversion of atrial fibrillation and thyroid hormone metabolism after mitral replacement in patients with rheumatic heart disease.
Qun-qing CHEN ; Jian TONG ; Yu-sheng YAN ; Fu-wei ZHANG
Journal of Southern Medical University 2010;30(11):2548-2550
OBJECTIVETo analyze the relationship between early spontaneous cardioversion of atrial fibrillation (AF) and thyroid hormone metabolism after mitral replacement in patients with rheumatic heart disease, and explore the treatment strategy of early spontaneous cardioversion after mitral valve replacement.
METHODSAccording to the occurrence of cardioversion, 138 patients with mitral valve replacement were divided into conversion group and non-conversion group, and based on the duration of sinus rhythm, the patients in conversion group were divided into < 3 days group and > 3 days group. Triiodothyronine (T3) was detected by radioimmunoassay in all the patients.
RESULTST3 metabolism decreased significantly after the operation in all the patients. Early spontaneous cardioversion of AF occurred 2 h after the operation in 52 cases (37.7%), and 28 (20.3%) of the cases had a duration of sinus rhythm longer than 3 days. T3 was significantly decreased in conversion group and non-conversion group by 44.5% and 58.7% at 2 h, by 40.0% and 52.4% at 24 h and by 28.6% and 37.7% at 72 h after the operation, respectively. The levels of T3 in conversion group was significantly higher than the levels in non-conversion group, and showed no significant variation with the duration of sinus rhythm.
CONCLUSIONEnhancement of T3 levels after mitral valve replacement may increase the probability of early spontaneous cardioversion of AF, but can not affect the duration of sinus rhythm. This finding supports the supplementation of T3 perioperatively in patients undergoing cardiac surgeries.
Adult ; Aged ; Atrial Fibrillation ; physiopathology ; Electric Countershock ; Female ; Heart Valve Prosthesis Implantation ; Humans ; Male ; Middle Aged ; Mitral Valve ; surgery ; Postoperative Period ; Rheumatic Heart Disease ; metabolism ; physiopathology ; surgery ; Thyroid Gland ; metabolism ; Thyroid Hormones ; metabolism ; Treatment Outcome ; Young Adult
9.Study on protective effect of shenfu injection on cardiac function of patients undergoing valve replacement.
Hui DONG ; Li-ze XIONG ; Min CHEN
Chinese Journal of Integrated Traditional and Western Medicine 2004;24(1):32-35
OBJECTIVETo investigate the protective effect of Shenfu injection (SFI) on cardiac function of patients undergoing valve replacement operation under cardio-pulmonary bypass.
METHODSOne hundred and twenty patients undergoing valve replacement operation under cardio-pulmonary bypass were randomly divided into the SFI group and the control group, 60 in each group. Intravenous infusion of 1 ml/kg SFI was given to the SFI group, 30 min before anesthesia, and to the control group, equal volume of normal saline was given instead. The following indices were observed: (1) the hemodynamic changes occurred in the operational period; (2) the dosage of vaso-active drugs used during and after operation; (3) the post-operational recovery time of patients.
RESULTSThe mean arterial pressure and heart rate in the SFI group during operation were higher, while the central venous pressure was lower than those in the control group (P < 0.05). The dosage of vaso-active drugs, such as dopamine, dobutamine, sodium nitroprusside and lidocaine, used during and after operation was lower, and the extubation time and the intensive care unit (ICU) staying time were shorter in the SFI group when compared with those in the control group (P < 0.05).
CONCLUSIONSFI has certain protective effects on the cardiac function of patients undergoing valve replacement operation under cardio-pulmonary bypass.
Adolescent ; Adult ; Aortic Valve Insufficiency ; drug therapy ; physiopathology ; surgery ; Cardiopulmonary Bypass ; Dopamine ; therapeutic use ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Heart Valve Prosthesis Implantation ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Mitral Valve Insufficiency ; drug therapy ; physiopathology ; surgery ; Nitroprusside ; therapeutic use ; Phytotherapy ; Postoperative Period ; Rheumatic Heart Disease ; drug therapy ; physiopathology ; surgery